N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)

C95H108F6N16O11 — CID 165043471

IUPACN-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)
SMILESCC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(OCC4CC4)cc3n2)CC1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.O=C(Nc1cc2cn(C3CCC(O)CC3)nc2cc1OCC1CC1)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C25H27F3N4O2.C24H25F3N4O3.2C23H28N4O3/c1-15-5-9-18(10-6-15)32-13-17-11-21(22(12-20(17)31-32)34-14-16-7-8-16)30-24(33)19-3-2-4-23(29-19)25(26,27)28;25-24(26,27)22-3-1-2-18(28-22)23(33)29-20-10-15-12-31(16-6-8-17(32)9-7-16)30-19(15)11-21(20)34-13-14-4-5-14;2*1-14-5-4-6-19(24-14)22(29)25-21-11-15-13-27(16-7-9-17(28)10-8-16)26-20(15)12-18(21)23(2,3)30/h2-4,11-13,15-16,18H,5-10,14H2,1H3,(H,30,33);1-3,10-12,14,16-17,32H,4-9,13H2,(H,29,33);2*4-6,11-13,16-17,28,30H,7-10H2,1-3H3,(H,25,29)
InChIKeyONAMPKRDSBXMSV-UHFFFAOYSA-N
MW1764.00 g/mol
LogP18.60
Rot. Bonds20

About N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)

N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) (PubChem CID 165043471) has the molecular formula C95H108F6N16O11 and a molecular weight of 1764.00 g/mol. Its IUPAC name is N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide).

Molecular Properties

Compound NameN-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)
PubChem CID165043471
Molecular FormulaC95H108F6N16O11
Molecular Weight1764.00 g/mol
Exact Mass1762.83
IUPAC NameN-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)
SMILESCC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(OCC4CC4)cc3n2)CC1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.O=C(Nc1cc2cn(C3CCC(O)CC3)nc2cc1OCC1CC1)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C25H27F3N4O2.C24H25F3N4O3.2C23H28N4O3/c1-15-5-9-18(10-6-15)32-13-17-11-21(22(12-20(17)31-32)34-14-16-7-8-16)30-24(33)19-3-2-4-23(29-19)25(26,27)28;25-24(26,27)22-3-1-2-18(28-22)23(33)29-20-10-15-12-31(16-6-8-17(32)9-7-16)30-19(15)11-21(20)34-13-14-4-5-14;2*1-14-5-4-6-19(24-14)22(29)25-21-11-15-13-27(16-7-9-17(28)10-8-16)26-20(15)12-18(21)23(2,3)30/h2-4,11-13,15-16,18H,5-10,14H2,1H3,(H,30,33);1-3,10-12,14,16-17,32H,4-9,13H2,(H,29,33);2*4-6,11-13,16-17,28,30H,7-10H2,1-3H3,(H,25,29)
InChIKeyONAMPKRDSBXMSV-UHFFFAOYSA-N
XLogP18.60
TPSA358.85 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds20
Heavy Atoms128
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001764.00
LogP ≤ 518.60
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Analyze N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US9951086, Example 48
CID 118173176
US9951086, Example 52
CID 118182538
US11065231, Example 63
CID 138657242
US20240423977, Example II-16
CID 175664355
N-[2-[2-[4-(2-hydroxypentan-2-yl)piperidin-1-yl]-2-oxoethyl]-6-(pyridin-2-ylmethoxy)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 134422811
N-[2-[2-[4-(1-hydroxyethyl)piperidin-1-yl]-2-oxoethyl]-6-(pyridin-2-ylmethoxy)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 134422812
N-[6-(cyclopropylmethoxy)-2-[2-[4-(2-hydroxypentan-2-yl)piperidin-1-yl]-2-oxoethyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 134422930
N-[6-(1-acetylpiperidin-4-yl)oxy-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 154970190
N-[6-cyclopropyloxy-2-[4-(hydroxymethyl)cyclohexyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155437918
tert-butyl N-[(2S)-1-[[(2S)-1-[(3S)-7-[3-[7-[[4-[6-methoxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]propoxy]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
CID 155437959
tert-butyl N-[1-[[1-[(3S)-7-[3-[7-[[4-[6-methoxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]propoxy]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
CID 155437963
N-[2-[4-(hydroxymethyl)cyclohexyl]-6-propan-2-yloxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438042

Frequently Asked Questions

What is the IUPAC name of N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)?
The IUPAC name of N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) (CID 165043471) is N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide).
What is the SMILES notation for N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)?
The canonical SMILES for N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) is CC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(OCC4CC4)cc3n2)CC1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.Cc1cccc(C(=O)Nc2cc3cn(C4CCC(O)CC4)nc3cc2C(C)(C)O)n1.O=C(Nc1cc2cn(C3CCC(O)CC3)nc2cc1OCC1CC1)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)?
The InChIKey is ONAMPKRDSBXMSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27F3N4O2.C24H25F3N4O3.2C23H28N4O3/c1-15-5-9-18(10-6-15)32-13-17-11-21(22(12-20(17)31-32)34-14-16-7-8-16)30-24(33)19-3-2-4-23(29-19)25(26,27)28;25-24(26,27)22-3-1-2-18(28-22)23(33)29-20-10-15-12-31(16-6-8-17(32)9-7-16)30-19(15)11-21(20)34-13-14-4-5-14;2*1-14-5-4-6-19(24-14)22(29)25-21-11-15-13-27(16-7-9-17(28)10-8-16)26-20(15)12-18(21)23(2,3)30/h2-4,11-13,15-16,18H,5-10,14H2,1H3,(H,30,33);1-3,10-12,14,16-17,32H,4-9,13H2,(H,29,33);2*4-6,11-13,16-17,28,30H,7-10H2,1-3H3,(H,25,29).
What are the key properties of N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide)?
N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) has a molecular weight of 1764.00 g/mol, XLogP of 18.60, 20 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-(cyclopropylmethoxy)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(N-[2-(4-hydroxycyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-methylpyridine-2-carboxamide) is sourced from PubChem (CID 165043471), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).